Andrew L. Mcelroy

Urology
1000 East Paris Ave SE Ste 230
Grand Rapids, MI 49546

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses.

The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses.

Journal: Urologic oncology
Published: July 25, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026